“Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension Patients Linked to Severe Inflammation and Poor Prognosis”

https://pubmed.ncbi.nlm.nih.gov/38116660

Clonal hematopoiesis of indeterminate potential (CHIP) is present in 9.4% of patients with chronic thromboembolic pulmonary hypertension (CTEPH), associated with a severe inflammatory state, and confers a poorer prognosis in long-term follow-up.